Beijing Business Today Oct. 13th, 2010
Fosun International (00656.HK) announced that it s A-share subsidiary, Shanghai Fosun Pharma will increase RMB 122 million investment to Beijing Golden Elephant Pharmacy. After the capital increase, the shares of Golden Elephant Pharmacy held directly by Fosun Pharma will increase from 5% to 55%.
As per statements from Fosun Pharma, it intends to further enlarge its overall scale of medicine retail business, improve significantly its bargaining power, product management and operation by this capital increase, since it is admitted Golden Elephant Pharmacy s position and brand impact in current medicine retail industry of China.
According to the report from management of Golden Elephant Pharmacy, the total assets of Golden Elephant Pharmacy is about RMB 188 million as of this June 30th. From this January to June, its sale turnover is nearly RMB 175 million, and achieves net profit attributable to shareholders of parent company RMB 2.37 million.
Related News
Photos
More>>
trade
- Innovation and paSsion: Tasly SA innovated various marketing methods
- Tasly South Africa East London Office Attends a Local Exhibition
- Tasly Ghana held Training Seminar in Takoradi
- Care the Elderly to Prevent Cardiovascular Disease Tasly Mozambique Organized
- New Specialty Store Opened & Motivational Meeting Called in Daloa
market
- Malaysian PM Dato Seri Najib Evaluates Highly on Taslian Products
- Tasly Congo Calls First Distributors Conference
- Tasly World Zambia management in Lubumbashi(Congo DRC) for market development
- Tasly Zambia Obtains Practical Results in Media Marketing
- Tasly C.I Held Motivating Meeting For Weak Shop Owners